← All organizations

Excel Diagnostics and Nuclear Oncology Center

Academic/HospitalWebsite ↗

Also known as: Excel Diagnostics and Nuclear Oncology Center | Excel Diagnostics and Nuclear Oncology Clinic

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 16, 2021

Timeline

2000s

Jan 1, 2003
Excel Diagnostics and Nuclear Oncology Center— Founded

Drugs by trial phase (7 distinct, 7 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

octreotate

Indications

Studied for

Recent trials (12)

NCT05219500Lead sponsorPhase 2Dec 16, 2021
NCT05219500Overall official - principal investigatorPhase 2Dec 16, 2021
NCT04276597Lead sponsorPhase 2Mar 1, 2020
NCT04276597Overall official - principal investigatorPhase 2Mar 1, 2020
NCT04276597Study directorPhase 2Mar 1, 2020
NCT03466216Overall official - principal investigatorPhase 1Feb 5, 2018
NCT03042312Overall official - principal investigatorPhase 2Apr 11, 2017
NCT03042312Lead sponsorPhase 2Apr 11, 2017
NCT02282137CollaboratorPhase 2Apr 1, 2015
NCT01879657CollaboratorPhase 1/Phase 2Mar 1, 2013
NCT01237457Overall official - principal investigatorPhase 2Oct 1, 2010
NCT01237457Sponsor investigatorPhase 2Oct 1, 2010

Details

Founded: Houston, TX, US Jan 1, 2003
Last known activity: Dec 16, 2021